DATE: Friday, October 12, 2018
TIME: 7:00PM-9:00PM
LOCATION: Riverside Ballroom, Sheraton New York, Time Square
Questions or Assistance: Please Click Here >>
| PROGRAM DESCRIPTION |
New insights from clinical research, coupled with technological innovation, continue to further our understanding of VT mechanisms and treatment strategies. VT centers worldwide are actively striving to achieve efficient, reproducible procedures with increased success rates, while minimizing radiation exposure. This evening program, led by our experienced faculty members, will address the following key concepts in VT ablation and explore practical, real-world applications through case study presentations, discussion and Q&A:
GET TO THE POINTS THAT MATTER:
Maximize automated high-density mapping to quickly collect relevant data and reduce overall procedure time
FRACTIONATION AT ITS FINEST:
Rapidly recognize LPs, LAVAs and other critical fractionated signals
CIRCUIT DECONSTRUCTION:
Use novel tools to efficiently understand and diagnose the VT mechanism
TARGET, TITRATE AND TREAT:
Tailor your ablation strategy and focus your treatment approach
“IS THIS THE END?”:
Considerations on ablation endpoints
VT “UNLEADED”:
Learn advanced imaging techniques with ultrasound and 3D navigation to reduce your radiation exposure and orthopedic burden of wearing lead
| AGENDA |
|
7:00PM-7:30PM |
REGISTRATION, COCKTAIL RECEPTION AND DINNER |
|
|
7:30PM-7:40PM |
WELCOME AND INTRODUCTIONS |
|
|
7:40PM-8:40PM |
CASE STUDIES PRESENTATIONS |
|
|
8:40PM-9:00PM |
PANEL DISCUSSION, Q&A SESSION |
| FACULTY |
|
William G. Stevenson, MD |
Andrew Brenyo, MD, FACC, FHRS |
||
|
Wendy S. Tzou, MD, FHRS, FACC |
Albert Y. Sun, MD |
||
The AdvaMed® Code of Ethics limits attendance at corporate sponsored events to healthcare professionals with a bona fide professional interest in the program. Because Biosense Webster, Inc. is committed to following the AdvaMed® Code, spouses, significant others or other guests may not attend this event. Due to state laws, Biosense Webster, Inc. cannot provide meals to Vermont HCPs in the context of product promotions. Information relating to any transfer of value provided to you due to your attendance at this event (i.e., paid or reimbursed travel expenses, meal costs) may be disclosed to the government dependent upon your professional license, in accordance with the federal Open Payments Program and state transparency reporting laws. If you do not wish this information to be disclosed to the government, you should abstain from attending.
Caution: US law restricts this device to sale by or on the order of a physician.
Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.
Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO® System User Guide regarding recommendations for fluoroscopy use. Pellegrino, P.L., Brunetti, N.D., Gravina, D., Sacchetta, D., De Sanctis, V., Panigada, S., Di Biase, L., Di Biase, M., and Mantica, M. (2013). Nonfluoroscopic mapping reduces radiation exposure in ablation of atrial fibrillation. Journal of cardiovascular medicine 14, 528-533. Earley, M.J., Showkathali, R., Alzetani, M., Kistler, P.M., Gupta, D., Abrams, D.J., Horrocks, J.A., Harris, S.J., Sporton, S.C., and Schilling, R.J. (2006). Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J 27, 1223-1229
The third party trademarks used herein are the properties of their respective owners.
© Biosense Webster, Inc. 2018. 097729-180827
